Vaccinia Immune Globulin (Human)

CHEBI:CHEBI_748977

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

rxcui
1922334
product_type
HUMAN PRESCRIPTION DRUG
listing_expiration_date
20251231
dosage_form
INJECTION
route
INTRAVENOUS
marketing_category
BLA
pharm_class_epc
Human Immunoglobulin G [EPC]
pharm_class
Virus-specific Hyperimmune Globulins [EXT]
pharm_class_cs
Immunoglobulins [CS]
pharm_class_pe
Passively Acquired Immunity [PE]
package_marketing_start_date
20180112
generic_name
Vaccinia Immune Globulin (Human)
brand_name
CNJ-016
brand_name_base
CNJ-016
product_ndc
60492-0173
application_number
BLA125109
labeler_name
Emergent BioSolutions Canada Inc.
manufacturer_name
Emergent BioSolutions Canada Inc.
marketing_start_date
20050501
spl_id
3bb56e1d-118d-44b5-8768-fe1f47818977
active_ingredient_name
HUMAN VACCINIA VIRUS IMMUNE GLOBULIN
active_ingredient_strength
1 [iU]/mL
package_ndc
60492-0173-2
package_description
24 VIAL, SINGLE-USE in 1 CARTON (60492-0173-2) / 12 mL in 1 VIAL, SINGLE-USE (60492-0173-1)
unii
7UB4J759TD
spl_set_id
a4f9f620-e6e4-4a03-a9a7-79007c8c2cfe
nui
M0011122
upc
0360492017321
pharm_class_moa
Virus Neutralization [MoA]
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class